Journal Article a Wild Card in Vioxx Trial (AP)
|
|
Merck Pharmaceutical Company in Lansdale, Pennsylvania. Merck and Co. recorded better-than-expected earnings in the fourth quarter, while putting aside more money to deal with lawsuits over its pain medication Vioxx.(AFP/File/Tom Mihalek)
AP - A top medical journal's criticism of a study cited in Vioxx lawsuits is expected to play a part in the retrial of the first federal Vioxx lawsuit — but it's not clear if it will be a legal hand grenade or a nuclear warhead. |
|
|